Ranjan Pai is among India’s most influential investors. So, when he makes a move into senior care, it is time to sit up and take notice of the sector, not to mention the broader grey economy.
Related Posts
How a scientist at Enzene is rethinking manufacturing to make anti-cancer drugs affordable in India
Himanshu Gadgil, CEO, Enzene Biosciences; Enzene Biosciences in Pune; image credit: Enzene Synopsis Anti-cancer drugs are beyond the reach of…
us shark tank: Selling cut-price generics, Mark Cuban is shaking up US pharma. Can Indian drug makers benefit?
Getty Images Mark Cuban. Synopsis Most of the large Indian pharma companies earn a big chunk of their revenue by…
With data, we want to boost genomics, personalised medicines, manufacturing: WEF health chief
Shyam Bishen, chief of health and healthcare division, World Economic Forum; image credit: Twitter Synopsis The scars from the pandemic…
